» Articles » PMID: 12842710

Hemangioblastic Characteristics of Fetal Bone Marrow-derived Flk1(+)CD31(-)CD34(-) Cells

Overview
Journal Exp Hematol
Specialty Hematology
Date 2003 Jul 5
PMID 12842710
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate whether Flk1(+)CD31(-)CD34(-) cells isolated from fetal bone marrow (BM) have characteristics of hemangioblasts, i.e., progenitors of endothelial and hematopoietic cells.

Materials And Methods: Mononuclear cells from fetal BM were negatively sorted by CD45, GlyA, and CD34 micromagnetic beads, then cultured to form cell colonies. A single colony was harvested. Culture-expanded cells were seeded on ECM gel or semisolid media supplemented with endothelial and hematopoietic growth factors, respectively. Immunochemistry staining and RT-PCR were performed for cell characterization.

Results: 99% of cells from the single colony maintained Flk1(+) and CD31/CD34(-) during passaging. On ECM gel, Flk1(+)CD31(-)CD34(-) cells could grow into vascular structure that was positive for CD31 and vWF. There were round CD34(+) cells around the vascular structure. When angiogenesis inhibitor suramin was added before tube formation, formation of vascular structure was blocked. Additionally, Flk1(+)CD31(-)CD34(-) cells cultured on hematopoietic condition could differentiate into hematopoietic cells which expressed GATA-1, 2, and gamma, beta globin gene. After being replated in methylcellulose medium, they formed typical erythroid colonies.

Conclusions: Flk1(+)CD31(-)CD34(-) cells derived from fetal BM could differentiate into endothelial and hematopoietic cells. The results suggested that these Flk1(+)CD31(-)CD34(-) cells after embryo stage bear characteristics of hemangioblast and may have potential application for the hematopoietic and vascular diseases.

Citing Articles

Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis.

Chilla A, Margheri F, Biagioni A, Del Rosso M, Fibbi G, Laurenzana A J Exp Clin Cancer Res. 2018; 37(1):74.

PMID: 29615071 PMC: 5883600. DOI: 10.1186/s13046-018-0742-2.


Molecular biological characteristics of the recruitment of hematopoietic stem cells from bone marrow niche in chronic myeloid leukemia.

Zhu B, Zhang J, Chen J, Li C, Wang X Int J Clin Exp Pathol. 2016; 8(10):12595-607.

PMID: 26722450 PMC: 4680395.


BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblasts.

Li Q, Wu Y, Fang S, Wang L, Qi H, Zhang Y Cancer Gene Ther. 2015; 22(5):227-37.

PMID: 25837664 DOI: 10.1038/cgt.2014.65.


Pluripotent stem cells exhibiting similar characteristics can be isolated from human fetal bone marrow, heart, liver, muscle, lung, derma, kidney, and fat.

Fang B, Song Y, Zhao C, Shi M, Lin Q Front Med China. 2014; 1(2):185-91.

PMID: 24557674 DOI: 10.1007/s11684-007-0035-1.


The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromes.

Wang Z, Tang X, Xu W, Cao Z, Sun L, Li W PLoS One. 2013; 8(3):e57470.

PMID: 23469196 PMC: 3587596. DOI: 10.1371/journal.pone.0057470.